News
Jefferies analyst Surinder Thind maintained a Buy rating on Genpact (G – Research Report) today and set a price target of $56.00. The company’s ...
The founder of menopause startup Gennev steps down, while the CEO and founder of Aurion Biotech is pushed out, plus other ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback